TumorGen and PhenoVista Capture the Seeds that Drive Cancer Metastasis

SAN DIEGO–(BUSINESS WIRE)– #FightMetastasis–TumorGen Inc., and PhenoVista Biosciences LLC have successfully isolated and characterized metastatic cancer cell clusters (MCCCs) from the blood of lung cancer patients’, validating TumorGen’s novel MCCC capture technology. This achievement is a critical milestone in developing anti-metastatic drugs, called “cluster busters,” which will target these cells and prevent cancer metastasis. “Anti-metastatic therapies that can stop tumors from forming in other organs is a
Click here to view original post